Tudor Investment Corp’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Hold
0
3558
2025
Q4
Hold
0
3470
2025
Q3
Hold
0
3339
2025
Q2
Hold
0
3212
2025
Q1
Hold
0
3027
2024
Q4
Sell
-3,386
Closed -$890K 2988
2024
Q3
$931K Sell
3,386
-57,007
-94% -$14.8M 0.01% 1666
2024
Q2
$14.7M Buy
+60,393
New +$9.53M 0.16% 250
2024
Q1
Sell
-64,096
Closed -$12.3M 2182
2023
Q4
$12.3M Buy
64,096
+4,092
+7% +$697K 0.17% 274
2023
Q3
$10.6M Buy
60,004
+51,377
+596% +$9.8M 0.16% 214
2023
Q2
$1.64M Buy
+8,627
New +$1.71M 0.03% 1010
2022
Q4
Sell
-29,859
Closed -$5.98M 2336
2022
Q3
$5.98M Buy
29,859
+28,014
+1,518% +$5.34M 0.15% 178
2022
Q2
$269K Buy
+1,845
New +$262K 0.01% 1633
2022
Q1
Sell
-24,057
Closed -$4.08M 1966
2021
Q4
$4.08M Sell
24,057
-4,196
-15% -$780K 0.08% 335
2021
Q3
$5.33M Buy
+28,253
New +$5.3M 0.11% 246
2021
Q2
Sell
-19,022
Closed -$2.69M 1579
2021
Q1
$2.69M Buy
+19,022
New +$2.86M 0.06% 393
2020
Q2
Sell
-3,667
Closed -$399K 1152
2020
Q1
$399K Sell
3,667
-2,077
-36% -$240K 0.04% 581
2019
Q4
$662K Buy
+5,744
New +$573K 0.03% 637
2019
Q3
Sell
-29,989
Closed -$2.18M 1065
2019
Q2
$2.18M Buy
+29,989
New +$2.3M 0.08% 299
2015
Q1
Sell
-3,540
Closed -$343K 1431
2014
Q4
$343K Buy
+3,540
New +$328K 0.02% 964

Other funds holding ALNY